Research firm GoodFirms said on Thursday that the hospitals are adapting various healthcare software to maintain and manage the records to reduce the viral transmission between patients and providers via the exchange of files or prescriptions during the COVID-19 crisis.
In the face of COVID-19, most healthcare departments, pharmacy companies and medical practice institutes have invested in software to keep the information confidential and secure and make it easier to get the data in just one click.
However, various health professionals and healthcare facility providers are facing challenges to pick the right tool. Therefore, GoodFirms.co has evaluated a list of Medical Practice Management, Medical Transcription, Mental Health, Chiropractic, Child Care, Dental Practice, Electronic Medical Records and Hospital Management Software.
The firm is providing Best Medical Practice Management Software, Best Medical Transcription Software, Best Mental Health Software, Best Chiropractic Management Software, Best Child Care Software, Best Dental Practice Software, Best Electronic Medical Records Software as well as Best Hospital Management Software to increase productivity and earn more revenue during the pandemic.
Relay Therapeutics wins FDA breakthrough status for zovegalisib in breast cancer treatment
DATROWAY receives US priority review for first-line metastatic triple negative breast cancer
Valneva and Instituto Butantan launch pilot chikungunya vaccination campaign in Brazil
Lupin launches Dasatinib tablets in US market
WuXi Biologics enters into licence and research service agreement with Vertex Pharmaceuticals
Natera submits Signatera CDx PMA to FDA for bladder cancer use
Pharming receives FDA complete response letter for paediatric Joenja application
Astrazeneca Imfinzi perioperative regimen gains positive EU CHMP opinion in early gastric cancer
I Peace generates human iPS cells from NKT cells and offers them for research use
Trace Biosciences' IND application for nerve-specific imaging agent approved by FDA
Frontage expands early phase clinical research capabilities across US and China
AstraZeneca agrees obesity and type 2 diabetes collaboration with CSPC
Ascletis Pharma Inc reports topline results from Phase III open-label study of denifanstat
Innovative Molecules GmbH completes Phase 1 clinical development programme for adibelivir
MicuRx Pharmaceuticals' IND application for MRX-5 cleared by FDA